Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation
Aimei Liu, Qinghua Wu, Dapeng Peng, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1973-2018
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 136
RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis
Ha Zhu, Kun Chen, Yali Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
Xiaoli Liao, Junming Chen, DongCheng Luo, et al.
Pathology & Oncology Research (2023) Vol. 28
Open Access | Times Cited: 19
Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
Jin-Cui Yang, Junjie Hu, Yixin Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Methylation-sensitive transcription-enhanced single-molecule biosensing of DNA methylation in cancer cells and tissues
Ziwei Han, Fei Ma, Chun‐yang Zhang
Analytica Chimica Acta (2023) Vol. 1251, pp. 340996-340996
Closed Access | Times Cited: 13
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy
Chi Xu, Shuyun Jiang, Xingyu Ma, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 2, pp. 441-456
Closed Access | Times Cited: 19
Atomic Force Microscopy Detects the Difference in Cancer Cells of Different Neoplastic Aggressiveness via Machine Learning
Siona Prasad, Alex Rankine, Tarun Prasad, et al.
Advanced NanoBiomed Research (2021) Vol. 1, Iss. 8
Open Access | Times Cited: 24
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
Lingyu Zhang, Yu Li, Yibei Dai, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma
Aalok Basu, Thanaphon Namporn, Pakatip Ruenraroengsak
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1611-1611
Open Access | Times Cited: 9
Updates on the Diagnosis and Management of Hepatocellular Carcinoma
Aimun Raees, Muhammad Kamran, Hasan Özkan, et al.
Euroasian Journal of Hepato-Gastroenterology (2021) Vol. 11, Iss. 1, pp. 32-40
Open Access | Times Cited: 18
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 13
Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma
Alireza Tojjari, James Yu, Anwaar Saeed
Cancers (2024) Vol. 16, Iss. 5, pp. 1058-1058
Open Access | Times Cited: 2
Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
Dan Li, Tao Yu, Jingjing Han, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 11
Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma
Qicheng Liu, Feng Lu, Zhong Chen
Pathology - Research and Practice (2020) Vol. 216, Iss. 11, pp. 153213-153213
Closed Access | Times Cited: 16
A novel DNA methylation‐driver gene signature for long‐term survival prediction of hepatitis‐positive hepatocellular carcinoma patients
Jie Fu, Wei Qin, Qing Tong, et al.
Cancer Medicine (2022) Vol. 11, Iss. 23, pp. 4721-4735
Open Access | Times Cited: 8
miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation
Yuqiang Li, Bin Wu, Rongli Sun, et al.
Autoimmunity (2021) Vol. 54, Iss. 8, pp. 547-560
Closed Access | Times Cited: 11
Construction of a prognostic model based on genome-wide methylation analysis of miRNAs for hepatocellular carcinoma
Zhaoqi Shi, Xiaolong Liu, Duguang Li, et al.
Epigenomics (2024) Vol. 16, Iss. 8, pp. 513-527
Closed Access | Times Cited: 1
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
Lin Su, Jiawen Bu, Jiahui Yu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 1
Mechanism of miR ‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
Hongcheng Lv, Yanyan Lv, Gang Wang, et al.
The Kaohsiung Journal of Medical Sciences (2022) Vol. 38, Iss. 4, pp. 336-346
Open Access | Times Cited: 7
Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
Youfu Zhang, Xuyang Wang, Huaxiang Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
The lncRNA KIF9-AS1 Accelerates Hepatocellular Carcinoma Growth by Recruiting DNMT1 to Promote RAI2 DNA Methylation
Yong Yu, Xianghong Lü, Yan Yang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 7
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
Loraine Kay D. Cabral, Peter Andrew C. Reyes, Lory Saveria Crocè, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1825-1825
Open Access | Times Cited: 9
Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer
Xing Chen, Guihai Liu, Buqiang Wu
Heliyon (2023) Vol. 9, Iss. 11, pp. e21164-e21164
Open Access | Times Cited: 3
Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma
Junhai Pan, Duguang Li, Xiaoxiao Fan, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 3, pp. 140-150
Closed Access | Times Cited: 3
Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
Hui Chen, Chun‐Ting Zhang, Qianmei Zhou, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top